Taken together, according to our study, HBV DNA polymerase inhibits the nuclear translocation of PARP1 by interacting with PARP1, thereby upregulating the expression of PD-L1 in tumor cells at the transcriptional level. The gene discussed is PARP1; the disease is neoplasm.